Strikingly, Zhou’s group designed a peptide mimicking the role of VGLL4 (an inhibitor for the YAP-TEAD interaction) to suppress the tumor growth in both xenograft and carcinogen-induced murine gastric tumor models32. Here, YAP1 is linked to gastric neoplasm.